Hello,
Welcome to the inaugural issue of the new, monthly newsletter of the Diabetes in Pregnancy Study Group of North America.
We are hoping to build community by sharing news and information consistently throughout the year, given that our conference occurs every other year. If you find this useful, please feel free to forward this to friends and coworkers.
We have launched a new website—please visit us online. We will post news, information, updates and conference proceedings here.
If you have news to share with others who study diabetes in pregnancy, please submit it here.
Sincerely,
Dr. E. Albert Reece, Co-Founder & Director
Dr. Sarah Crimmins, Program Chair
Dr. Scott Sullivan, Onsite Director and Sponsorship Chair
Registration Open and Abstracts Now Accepted for our 2025 Diabetes in Pregnancy Conference
New this year: the opportunity to participate in simulation activities at the Inova Center for Advanced Medical Simulation, a state-of-the-art sim center.
The exercise will be led by Dr. Shad Deering, a national leader in medical simulation training and patient safety. Dr. Deering created a division of medical simulation at Georgetown University Hospital, the Central Simulation Committee in the Army, and has led a $3.6M simulation collaboration between Baylor College of Medicine and Columbia University funded by NIH to improve operative management of postpartum hemorrhage. He holds a Bronze Star and several patents for an obstetric birthing simulator system. We are honored that he can offer this special opportunity to conference attendees.
Spots are available first-come, first served.
If you haven't already, now is the time to register for the conference, From Lab to Labor: Advancing Diabetes Care.
Call for Abstracts is Open
We are now accepting abstracts for presentations at our conference.
Here are just a few reasons you should consider submitting your work:
- Share your work with other researchers and frontline clinicians at the country's foremost conference dedicated to diabetes in pregnancy
- Network with other experts in the field
- Accepted submissions will be published in a special edition of the American Journal of Perinatology
- Manuscripts resulting from presented abstracts will be fast-tracked for publication in the American Journal of Perinatology
- Make an impact and improve care for diabetes in pregnancy
The deadline for submission is August 15th. Learn more and submit your work here.
Please share our call for abstracts with residents, fellows, early-stage investigators.
Diabetes in Pregnancy News
Technology
New Hybrid Closed-Loop Technology with Lower Target Blood Glucose
The Twiist automated insulin delivery (AID) system, developed by Sequel Med Tech, is expected to become commercially available in Q2 2025. Notably, this system allows for a target blood glucose as low as 87 mg/dL. This feature may be particularly relevant for pregnant patients, where tighter glucose targets are often necessary...
Treatment
Week-Long Insulin Will Be a Game-Changer, When FDA Approves it
Current options for insulin therapy for those with diabetes include fast acting and sustained acting insulin injections—but none last more than a day. Novo Nordisk’s insulin icodec—a weekly insulin being sold under the brand name Awiqli—has been approved for use in the EU, Canada, Australia, Japan, and Switzerland for type 1 and type 2 diabetes. It has also been approved in China for use in type 2 diabetes.
Here in the US, FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted last year 7—4 against approving insulin icodec for adults with type 1 diabetes...
Technology
First-Ever Year-Long Continuous Glucose Monitor Exciting, Holds Promise
Last year, the FDA approved use of the Eversense 365 year-long continuous glucose monitor (CGM) and approved its use with insulin pumps. Eversense 365 is the first CGM to work for as long as a year and is approved for those with type 1 diabetes mellitus 18 years or older. Other CGMs on the market typically last for one to two weeks...
Did someone forward this to you?
Subscribe to Get this Newsletter Monthly
